INVOS™ Patient Outcomes | Medtronic (NZ)

The only cerebral oximeter on the market to be tested and validated under varying levels of CO₂.
Documented clinical performance.
Clinical studies using the INVOS™ system demonstrate decreased occurrence of postoperative complications and improved outcomes.³^,⁴

INVOS™ RESOURCES

View supporting studies and resources.

1. Tomlin et al. Detection of critical cerebral desaturation thresholds by three regional oximeters during hypoxia: a pilot study in healthy volunteers. BMC Anesthesiology 2017, 17:6.
2. Borg U, A faster and deeper response to hypoxia. White paper 2018.
3. Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.
4. Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7(5):E376-381.

Contact Us

Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2025 Medtronic